WO2018115475A3 - Zusammensetzung enthaltend n-acetyldiaminobuttersäure - Google Patents
Zusammensetzung enthaltend n-acetyldiaminobuttersäure Download PDFInfo
- Publication number
- WO2018115475A3 WO2018115475A3 PCT/EP2017/084454 EP2017084454W WO2018115475A3 WO 2018115475 A3 WO2018115475 A3 WO 2018115475A3 EP 2017084454 W EP2017084454 W EP 2017084454W WO 2018115475 A3 WO2018115475 A3 WO 2018115475A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- containing composition
- acetyldiaminobutyric acid
- acetyldiaminobutyric
- acid
- composition
- Prior art date
Links
- IXNUDGNYEQZABZ-UHFFFAOYSA-N 2-acetamido-2-aminobutanoic acid Chemical compound CCC(N)(C(O)=O)NC(C)=O IXNUDGNYEQZABZ-UHFFFAOYSA-N 0.000 title abstract 3
- 150000002148 esters Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biophysics (AREA)
- Birds (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201780087060.3A CN110461321A (zh) | 2016-12-22 | 2017-12-22 | 含有n-乙酰基二氨基丁酸的组合物 |
US16/472,624 US20190380985A1 (en) | 2016-12-22 | 2017-12-22 | Composition Containing N-acetyldiaminobutyric Acid |
EP17872888.7A EP3558287A2 (de) | 2016-12-22 | 2017-12-22 | Zusammensetzung enthaltend n-acetyldiaminobuttersäure |
BR112019012788A BR112019012788A2 (pt) | 2016-12-22 | 2017-12-22 | composição contendo ácido n-acetildiaminobutírico |
MX2019007490A MX2019007490A (es) | 2016-12-22 | 2017-12-22 | Composicion que contiene acido n-acetildiamino butirico. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102016125414.2 | 2016-12-22 | ||
DE102016125414.2A DE102016125414A1 (de) | 2016-12-22 | 2016-12-22 | Zusammensetzung enthaltend N-Acetyldiaminobuttersäure |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018115475A2 WO2018115475A2 (de) | 2018-06-28 |
WO2018115475A3 true WO2018115475A3 (de) | 2018-08-23 |
Family
ID=62186383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2017/084454 WO2018115475A2 (de) | 2016-12-22 | 2017-12-22 | Zusammensetzung enthaltend n-acetyldiaminobuttersäure |
Country Status (7)
Country | Link |
---|---|
US (1) | US20190380985A1 (de) |
EP (1) | EP3558287A2 (de) |
CN (1) | CN110461321A (de) |
BR (1) | BR112019012788A2 (de) |
DE (1) | DE102016125414A1 (de) |
MX (1) | MX2019007490A (de) |
WO (1) | WO2018115475A2 (de) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993003714A2 (en) * | 1991-08-27 | 1993-03-04 | The Upjohn Company | Method for treatment of metabolic disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10262084B4 (de) | 2002-05-17 | 2009-12-24 | Dr. Franz Köhler Chemie GmbH | Protektive Lösung zur Verhinderung von Ischämieschäden |
DE10330243A1 (de) | 2003-07-03 | 2005-01-20 | bitop Aktiengesellschaft für biotechnische Optimierung | Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis |
DE102006056766A1 (de) | 2006-12-01 | 2008-06-05 | Bitop Ag | Verwendung von kompatiblen Soluten |
JP5781928B2 (ja) | 2008-07-16 | 2015-09-24 | ビトップ アーゲーbitop AG | 環状アミジンの合成 |
-
2016
- 2016-12-22 DE DE102016125414.2A patent/DE102016125414A1/de not_active Withdrawn
-
2017
- 2017-12-22 US US16/472,624 patent/US20190380985A1/en not_active Abandoned
- 2017-12-22 BR BR112019012788A patent/BR112019012788A2/pt not_active Application Discontinuation
- 2017-12-22 WO PCT/EP2017/084454 patent/WO2018115475A2/de unknown
- 2017-12-22 EP EP17872888.7A patent/EP3558287A2/de not_active Withdrawn
- 2017-12-22 CN CN201780087060.3A patent/CN110461321A/zh active Pending
- 2017-12-22 MX MX2019007490A patent/MX2019007490A/es unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993003714A2 (en) * | 1991-08-27 | 1993-03-04 | The Upjohn Company | Method for treatment of metabolic disorders |
Non-Patent Citations (2)
Title |
---|
CÁNOVAS D ET AL: "Role of Ngamma-acetyldiaminobutyrate as an enzyme stabilizer and an intermediate in the biosynthesis of hydroxyectoine", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 65, no. 9, 1 September 1999 (1999-09-01), pages 3774 - 3779, XP002253695, ISSN: 0099-2240 * |
RONQUIST G ET AL: "Antitumor activity of L-2,4 diaminobuturic acid against mouse fibrosarcoma cells in vitro and in vivo.", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 1980, vol. 96, no. 3, 1980, pages 259 - 268, XP009506043, ISSN: 0171-5216 * |
Also Published As
Publication number | Publication date |
---|---|
DE102016125414A1 (de) | 2018-06-28 |
CN110461321A (zh) | 2019-11-15 |
BR112019012788A2 (pt) | 2019-12-03 |
WO2018115475A2 (de) | 2018-06-28 |
US20190380985A1 (en) | 2019-12-19 |
EP3558287A2 (de) | 2019-10-30 |
MX2019007490A (es) | 2019-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501033A1 (en) | Oral care compositions and methods of use | |
MX2021007268A (es) | Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas. | |
EP3778605A3 (de) | Lrrk2-inhibitoren und verfahren zur herstellung und verwendung davon | |
EP3180009A4 (de) | Zoledronsäuredarreichungsformen zur behandlung von schmerzen | |
EP4282479A3 (de) | Verwendung von pridopidin zur behandlung von depression oder angst | |
EP4335507A3 (de) | Kombinationstherapie | |
MX2020006237A (es) | Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4. | |
EP3139939A4 (de) | Zusammensetzungen und verfahren zur behandlung von haut- und schleimhautmembranerkrankungen | |
WO2015197193A3 (en) | New use for jnk inhibitor molecules for treatment of various diseases | |
BR112017007144A2 (pt) | ácido valproico ou um sal farmaceuticamente aceitável do mesmo, composto, composição farmacêutica, e, composto ou composição para uso, uso, método ou composição. | |
EP3233091A4 (de) | Hypochlorsäureformulierungen und verfahren zur behandlung von hauterkrankungen | |
MX2017009417A (es) | Formas solidas de acido 2-(5-(3-fluorofenil)-3-hidroxipicolinamido )acetico, composiciones y usos de las mismas. | |
EP3949973A3 (de) | Zusammensetzungen und verfahren zur behandlung von depression | |
EP3456815A4 (de) | Wässrige lösung zur verabreichung an einen lebenden körper und verfahren zur herstellung davon | |
MX2015015162A (es) | Agente de reduccion de acido urico. | |
PH12017502069A1 (en) | Method for treating coffee rust, citrus black spot, citrus scab and banana black sigatoka diseases | |
MX2017001113A (es) | Composicion adhesiva. | |
PH12016501326A1 (en) | (s)-3'-methyl-abscisic acid and esters thereof | |
WO2015156674A3 (en) | Method for treating cancer | |
EP3475442A4 (de) | 12(s)-hydroxyeicosatriensäure-verbindungen und deren verwendung als therapeutika | |
WO2018115475A3 (de) | Zusammensetzung enthaltend n-acetyldiaminobuttersäure | |
GB2550750A (en) | Anthelmintic compounds | |
EP3612178A4 (de) | Vasodilatatoren zur behandlung von herzinsuffizienz | |
MX2016017321A (es) | Combinacicones y metodos para el tratamiento de dolor neuropatico. | |
EP3250166A4 (de) | Verfahren zur wiederherstellung des ansprechens auf ein medikament in gewebe von lebenden organismen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17872888 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112019012788 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2017872888 Country of ref document: EP Effective date: 20190722 |
|
ENP | Entry into the national phase |
Ref document number: 112019012788 Country of ref document: BR Kind code of ref document: A2 Effective date: 20190619 |